We are harnessing the power of machine learning to create better protein therapeutics. Working with partners from the pharmaceutical and biotechnology sector we deploy our platform, EVA, to solve complex protein engineering challenges and discover groundbreaking antibodies and antibody fragments.

Contact LabGenius via their website

News archive

20/04/2020   LabGenius Appoints Dr Edwin Moses as Chairman...more

23/10/2019   LabGenius raises $10M to use AI for protein drug discovery...more

19/08/2019   LabGenius named one of hottest start-ups by London's Wired Magazine...more

07/08/2019   LabGenius joins the BioPartner UK Programme...more

The BioPartner Programme

BPP members enjoy our full range of discounts, enhanced promotion on BioPartner UK Delegations and first refusal on new international opportunities.

Not a member? Join the BioPartnership Programme

BioPartner UK is a member of

Sponsors Alliance

Prompt Payment Code